1. CAR-T and CAR-NK therapy for the treatment of hematological malignancies
Directed by Álvaro Urbano Preclinical development of CARs for the treatment of malignant diseases. Specifically, we have developed a CAR against B...
Showing 5561 - 5580 de 10501 results
Directed by Álvaro Urbano Preclinical development of CARs for the treatment of malignant diseases. Specifically, we have developed a CAR against B...
Directed by Jaime de la Rocha We study how information, acquired from sensation or from previous experiences, is transformed into decision variabl...
Directed by Jaime de la Rocha We study how the brain maintains and uses information over short periods (working memory) using behavioral tasks in...
Directed by Hernando Martinez Vergara The Basal Ganglia (BG) are critical for learning, allowing vertebrates to adapt their behavior to maximize u...
Directed by Álvaro Urbano We are developing novel CAR-T cell therapies for the treatment of solid tumours, with a primary focus on breast and ovar...
Directed by Álvaro Urbano We use both NK cells and CAR-NK cells to increase the activity of CART cells avoiding CART cell exhaustion and increasin...
Directed by Álvaro Urbano GVHD and Infectious complications are the main problems occurring after allogeneic stem cell transplantation, being resp...
Our group’s scientific trajectory is focused on the study of the mechanisms involved in the development of haemorrhagic pathologies, particularly t...
Some diseases have a high cardiovascular risk, such as chronic kidney failure, diabetes, and obesity, among others, in which we surmise that endoth...
We have identified certain endothelial damage in the context of transplanted haematopoietic progenitor cells in patients. The behaviour of these ma...
Thrombotic microangiopathies (TMAs) have matching symptoms but may be due to quite different causes. Differential diagnosis of thrombotic thrombocy...
Platelet-derived microparticles facilitate interaction with other cell groups and may have a prothrombotic effect in certain pathological situation...
We have built unique prospective cohorts for the clinical and biological characterization of at-risk and prodromal Parkinson’s disease cohorts, e.g...
We seek, set-up and introduce clinically meaningful biomarkers. Hence, we pioneered the alpha-synuclein seed amplification assay in CSF, being the...
We investigate the pathophysiological mechanisms and pathways to unravel novel therapeutic targets of neurodegenerative movement disorders using hu...
Our group is currently investigating the endogenous phenotype that determines the heterogeneity of pulmonary hypertension in chronic airway obstruc...
To characterize the cell proliferative process that underlies the development of pulmonary hypertension in patients with thromboembolic pulmonary d...
The group is currently involved in a randomized control trial evaluating the impact of a prehabilitation program in the setting of cardiac surgery....
We are working on several physiological proof-of-concept studies and have promoted three international, multicentre, randomized controlled trials.
We are currently undertaking research projects addressed to clinical risk assessment and service selection, promotion of healthy lifestyles, collab...